BEGAN MARC A (VP & General Counsel) sold 12.7% of their position (2K shares) of ABIOMED INC on the open market
Open‑market sale worth $747.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock, $0.01 par value
Shares
−2K
Price / share
$373.71
Trade value
$747.42K
% of position
Common Stock, $0.01 par value
Shares
−1.55K
Price / share
$373.99
Trade value
$578.94K
% of position
Net shares
−3.55K
Net value
-$1.33M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par value Direct | 11/4/2022 | S · Sale | −2K | $373.71 | $747.42K | 12.7% | 15.79K | 13.79K |
| Common Stock, $0.01 par value Direct | 11/5/2022 | F · Tax Withholding | −1.55K | $373.99 | $578.94K | 11.2% | 13.79K | 12.24K |
| Total | −3.55K | -$1.33M | ||||||
Stock Option (Right to Buy)
DirectUnderlying shares
0.00
Shares owned
2.96K
Exercise price
283.88
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
0.00
Shares owned
5.13K
Exercise price
223.9
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
0.00
Shares owned
7K
Exercise price
266.39
Expiration
—
Exercise window
—
Underlying
0.00
Owned
15.09K
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 283.88 | — | — | 0.00 | 2.96K |
| Stock Option (Right to Buy) Direct | Common Stock | 223.9 | — | — | 0.00 | 5.13K |
| Stock Option (Right to Buy) Direct | Common Stock | 266.39 | — | — | 0.00 | 7K |
| Total | 0.00 | 15.09K | ||||